LVIS Stent Versus Enterprise Stent for the Treatment of Unruptured Intracranial Aneurysms
LVIS Stent Versus Enterprise Stent for the Treatment of Unruptured Intracranial Aneurysms
复制标题
LVIS 支架与 Enterprise 支架治疗未破裂颅内动脉瘤的比较
DOI:
10.1016/j.wneu.2016.04.057
复制
发表时间:
2016-07-01
影响因子:
2
通讯作者:
Li, Youxiang
中科院分区:
文献类型:
--
作者:
Ge, Huijian;Lv, Xianli;Li, Youxiang
OBJECTIVE: This retrospective study compared clinical and angiographic outcomes between LVIS and Enterprise stents.MATERIALS AND METHODS: From November 2014 to December 2015, total 190 patients with 208 unruptured intracranial aneurysms were coiled assisted by LVIS and Enterprise stents. Procedure-related complications, clinical outcomes, and angiographic results were analyzed retrospectively.RESULTS: A total of 92 patients with 96 aneurysms received LVIS stents and 98 patients with 112 aneurysms were treated with Enterprise stents. Procedure-related complications occurred in 10.9% of patients (2 hemorrhagic events and 8 thromboembolic events) in the LVIS stents group whereas 16.3% (1 hemorrhage, 1 mass effect, and 14 thromboembolic events) in the Enterprise stents group. No statistical significant differences in thromboembolic (P = 0.263), hemorrhagic complications (P = 0.611), and favorable clinical outcomes (modified Rankin Scores of 0-2) (P = 0.379) were found between 2 groups. A greater initial complete or near-complete obliteration was found in the LVIS stents group compared with the Enterprise stents group (96.9% vs. 88.4%, P = 0.034). Larger aneurysm size (P = 0.048) was an independent predictor of procedure-related complications in univariate analysis.CONCLUSIONS: Compared with Enterprise stents, LVIS stents may achieve greater complete or near-complete occlusion rate. There was no significant difference in procedural-related complications and clinical outcomes between LVIS and Enterprise stents.